Anthranilamide → HCID 57737846、化合物
反応式
[Br:1][C:2]1[S:3][CH:4]=[C:5]([C:7]([OH:9])=O)[N:6]=1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[NH2:34][C:35]1[CH:43]=[CH:42][CH:41]=[CH:40][C:36]=1[C:37]([NH2:39])=[O:38].C(N(CC)C(C)C)(C)C>CN(C)C=O>[NH2:39][C:37]([C:36]1[CH:40]=[CH:41][CH:42]=[CH:43][C:35]=1[NH:34][C:7]([C:5]1[N:6]=[C:2]([Br:1])[S:3][CH:4]=1)=[O:9])=[O:38]参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
2-Bromo-4-thiazolecarboxylic acid (1 g), HATU (2.01 g) and 2-aminobenzamide (0.65 g) are introduced into N,N-dimethylformamide (DMF) (20 ml). The mixture is cooled with an ice bath, and N,N-diisopropylethylamine (0.90 ml) is added. The reaction mixture is stirred at room temperature for 6 days, poured into ice-water and allowed to thaw with stirring, and the precipitated solid is filtered off with suction, washed twice with water, twice with diethyl ether and dried in vacuo. Intermediate III.2 is obtained as a solid (1.4 g).
後処理
- temperatureThe mixture is cooled with an ice bath
- stirringwith stirring
- filtrationthe precipitated solid is filtered off with suction
- washwashed twice with water, twice with diethyl ether
- customdried in vacuo
出典と根拠
- ORDレコード
- ord-77731f6d97124e189f08fdc3451fd289
- 出典データセット
- uspto-grants-2011_03
- 特許番号
- US07897626B2
反応ノート
読み込み中…